These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 38607765)

  • 1. The Body, the Brain, the Environment, and Parkinson's Disease.
    Dorsey ER; De Miranda BR; Horsager J; Borghammer P
    J Parkinsons Dis; 2024; 14(3):363-381. PubMed ID: 38607765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
    Uchihara T; Giasson BI
    Acta Neuropathol; 2016 Jan; 131(1):49-73. PubMed ID: 26446103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies.
    Martinez-Valbuena I; Amat-Villegas I; Valenti-Azcarate R; Carmona-Abellan MDM; Marcilla I; Tuñon MT; Luquin MR
    Acta Neuropathol; 2018 Jun; 135(6):877-886. PubMed ID: 29536165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.
    Schulz-Schaeffer WJ
    Acta Neuropathol; 2010 Aug; 120(2):131-43. PubMed ID: 20563819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology-associated change in levels and localization of SIDT2 in postmortem brains of Parkinson's disease and dementia with Lewy bodies patients.
    Fujiwara Y; Kabuta C; Sano T; Murayama S; Saito Y; Kabuta T
    Neurochem Int; 2022 Jan; 152():105243. PubMed ID: 34800582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Synuclein and Lewy pathology in Parkinson's disease.
    Kalia LV; Kalia SK
    Curr Opin Neurol; 2015 Aug; 28(4):375-81. PubMed ID: 26110807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
    Orimo S
    Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The brain-first vs. body-first model of Parkinson's disease with comparison to alternative models.
    Borghammer P
    J Neural Transm (Vienna); 2023 Jun; 130(6):737-753. PubMed ID: 37062013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propagation of alpha-synuclein pathology from the olfactory bulb: possible role in the pathogenesis of dementia with Lewy bodies.
    Cersosimo MG
    Cell Tissue Res; 2018 Jul; 373(1):233-243. PubMed ID: 29196808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Where and how alpha-synuclein pathology spreads in Parkinson's disease.
    Wakabayashi K
    Neuropathology; 2020 Oct; 40(5):415-425. PubMed ID: 32750743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological roles of α-synuclein in neurological disorders.
    Vekrellis K; Xilouri M; Emmanouilidou E; Rideout HJ; Stefanis L
    Lancet Neurol; 2011 Nov; 10(11):1015-25. PubMed ID: 22014436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-Nitrosylation of p62 Inhibits Autophagic Flux to Promote α-Synuclein Secretion and Spread in Parkinson's Disease and Lewy Body Dementia.
    Oh CK; Dolatabadi N; Cieplak P; Diaz-Meco MT; Moscat J; Nolan JP; Nakamura T; Lipton SA
    J Neurosci; 2022 Apr; 42(14):3011-3024. PubMed ID: 35169022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathological evidence of body-first vs. brain-first Lewy body disease.
    Borghammer P; Horsager J; Andersen K; Van Den Berge N; Raunio A; Murayama S; Parkkinen L; Myllykangas L
    Neurobiol Dis; 2021 Dec; 161():105557. PubMed ID: 34763110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease from the gut.
    Liddle RA
    Brain Res; 2018 Aug; 1693(Pt B):201-206. PubMed ID: 29360467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.
    Jellinger KA
    Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal cord lesions in sporadic Parkinson's disease.
    Del Tredici K; Braak H
    Acta Neuropathol; 2012 Nov; 124(5):643-64. PubMed ID: 22926675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.
    Ortuño-Lizarán I; Beach TG; Serrano GE; Walker DG; Adler CH; Cuenca N
    Mov Disord; 2018 Aug; 33(8):1315-1324. PubMed ID: 29737566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathologic analysis of Lewy-related α-synucleinopathy in olfactory mucosa.
    Funabe S; Takao M; Saito Y; Hatsuta H; Sugiyama M; Ito S; Kanemaru K; Sawabe M; Arai T; Mochizuki H; Hattori N; Murayama S
    Neuropathology; 2013 Feb; 33(1):47-58. PubMed ID: 22672612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson's disease.
    Castellani RJ; Nugent SL; Morrison AL; Zhu X; Lee HG; Harris PL; Bajić V; Sharma HS; Chen SG; Oettgen P; Perry G; Smith MA
    J Neural Transm (Vienna); 2011 Jan; 118(1):23-6. PubMed ID: 20972807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.